| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |